Methylprednisolone Completed Phase 2 Trials for Multiple Myeloma and Plasma Cell Neoplasm / Chronic Myeloproliferative Disorders / Myelodysplastic/Myeloproliferative Diseases / Congenital Hypoplastic Anemia / Aplastic Anemia / Myelodysplastic Syndromes (MDS) / Malignant Lymphomas / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00053989NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
NCT00003336Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions
NCT00003913Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
NCT00003960Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00458848Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia
NCT00002471Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
NCT00002785Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
NCT00022126Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
NCT00732498Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL
NCT00109928S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
NCT00002524Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
NCT00004323Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia